Oct 2023 $21 M No. 5 $10 to $50 million 19
Access Vascular, Inc.: Raise no. 5, Oct 2023 × Investors in this round 19 investors had bought by the notice of Oct 30, 2023: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $32 M offered; $11 M still to sell
Smallest investment taken $7,978
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James Biggins · Executive Officer Amine R Bentaleb · Director Brent Sabin · Director JJ Pelligrino · Director Luc R Marengere · Director Marc R Riviere · Director Michael R Jaff · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Biggins, President. Source: SEC Form D, newest notice filed Oct 30, 2023. Read the notice at the SEC .
equity, debt SEC Feb 2021 $20 M No. 4 $10 to $50 million 14
Access Vascular, Inc.: Raise no. 4, Feb 2021 × Investors in this round 14 investors had bought by the notice of Mar 9, 2021: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James Biggins · Executive Officer Alexandra R MacLean · Director Amine R Bentaleb · Director Brent Ratz · Director JJ Pelligrino · Director Luc R Marengere · Director Michael R Jaff · Director Paul Sabin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Biggins, President. Source: SEC Form D, newest notice filed Mar 9, 2021. Read the notice at the SEC .
equity, debt SEC Aug 2019 $6 M No. 3 $2 to $10 million 15
Access Vascular, Inc.: Raise no. 3, Aug 2019 × Investors in this round 15 investors had bought by the notice of Sep 9, 2019: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $7 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James Biggins · Executive Officer Brent Ratz · Director JJ Pelligrino · Director Paul Sabin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Biggins, President. Source: SEC Form D, newest notice filed Sep 9, 2019. Read the notice at the SEC .
equity SEC May 2018 $2 M No. 2 Under $2 million 7
Access Vascular, Inc.: Raise no. 2, May 2018 × Investors in this round 7 investors had bought by the notice of May 16, 2018: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James Biggins · Executive Officer, Director Brent Ratz · Director Joseph Pellegrino · Director Paul Sabin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Biggins, President. Source: SEC Form D, newest notice filed May 16, 2018. Read the notice at the SEC .
equity SEC Aug 2017 $4 M No. 1 $2 to $10 million 25
Access Vascular, Inc.: Raise no. 1, Aug 2017 × Investors in this round 25 investors had bought by the notice of Aug 16, 2017: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $15,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James Biggins · Executive Officer, Director Brent Ratz · Director Joseph Pellegrino · Director Paul Sabin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Biggins, President. Source: SEC Form D, newest notice filed Aug 16, 2017. Read the notice at the SEC .
equity SEC